BACKGROUND: Because both micronutrients and antimicrobial peptides protect against diarrhea, we looked for an effect on intestinal antimicrobial peptide gene expression during a randomized controlled trial of multiple micronutrient (MM) supplementation. METHODS:Consenting adults (n=287) in Lusaka, Zambia, were randomized to receive a daily MM supplement or placebo and were followed up for 3.3 years, with a crossover after 2 years. Intestinal biopsy samples were obtained at annual intervals, and messenger RNA of the intestinal antimicrobial peptides human alpha defensin (HD) 5, HD6, human beta-defensin (hBD) 1, hBD2, and LL-37 were quantified by real-time reverse-transcriptase polymerase chain reaction. Samples were also obtained during diarrhea episodes and after convalescence. RESULTS: There was no effect overall of treatment allocation. However, in malnourished adults (body mass index < or =18.5), HD5 mRNA was increased by 0.8 log transcripts/microg total RNA in MM recipients, compared with HD5 mRNA in placebo recipients (P=.007). During diarrhea, HD5 expression was reduced by 0.8 log transcripts in placebo recipients (P=.02) but was not reduced in MM recipients, nor was it reduced after the crossover. Correlations between HD5 and nutritional status were found that were sex-specific but not explained by serum leptin or adiponectin concentrations. CONCLUSIONS:Micronutrient supplementation was associated with up-regulation of HD5 only in malnourished adults. Interactions between antimicrobial gene expression and nutritional status may help to explain the increased risk of infection in individuals with malnutrition.
RCT Entities:
BACKGROUND: Because both micronutrients and antimicrobial peptides protect against diarrhea, we looked for an effect on intestinal antimicrobial peptide gene expression during a randomized controlled trial of multiple micronutrient (MM) supplementation. METHODS: Consenting adults (n=287) in Lusaka, Zambia, were randomized to receive a daily MM supplement or placebo and were followed up for 3.3 years, with a crossover after 2 years. Intestinal biopsy samples were obtained at annual intervals, and messenger RNA of the intestinal antimicrobial peptides human alpha defensin (HD) 5, HD6, humanbeta-defensin (hBD) 1, hBD2, and LL-37 were quantified by real-time reverse-transcriptase polymerase chain reaction. Samples were also obtained during diarrhea episodes and after convalescence. RESULTS: There was no effect overall of treatment allocation. However, in malnourished adults (body mass index < or =18.5), HD5 mRNA was increased by 0.8 log transcripts/microg total RNA in MM recipients, compared with HD5 mRNA in placebo recipients (P=.007). During diarrhea, HD5 expression was reduced by 0.8 log transcripts in placebo recipients (P=.02) but was not reduced in MM recipients, nor was it reduced after the crossover. Correlations between HD5 and nutritional status were found that were sex-specific but not explained by serum leptin or adiponectin concentrations. CONCLUSIONS: Micronutrient supplementation was associated with up-regulation of HD5 only in malnourished adults. Interactions between antimicrobial gene expression and nutritional status may help to explain the increased risk of infection in individuals with malnutrition.
Authors: Abdullah H Baqui; Robert E Black; Shams El Arifeen; Mohammad Yunus; Joysnamoy Chakraborty; Saifuddin Ahmed; J Patrick Vaughan Journal: BMJ Date: 2002-11-09
Authors: Nita H Salzman; Margaret M Chou; Hendrik de Jong; Lide Liu; Edith M Porter; Yvonne Paterson Journal: Infect Immun Date: 2003-03 Impact factor: 3.441
Authors: Jon D Kaiser; Adriana M Campa; Joseph P Ondercin; Gifford S Leoung; Richard F Pless; Marianna K Baum Journal: J Acquir Immune Defic Syndr Date: 2006-08-15 Impact factor: 3.731
Authors: Paul Kelly; Ian Menzies; Roger Crane; Isaac Zulu; Carole Nickols; Roger Feakins; James Mwansa; Victor Mudenda; Max Katubulushi; Steve Greenwald; Michael Farthing Journal: Am J Trop Med Hyg Date: 2004-04 Impact factor: 2.345
Authors: P Kelly; R Feakins; P Domizio; J Murphy; C Bevins; J Wilson; G McPhail; R Poulsom; W Dhaliwal Journal: Clin Exp Immunol Date: 2004-02 Impact factor: 4.330
Authors: Rose Banda; Vera Yambayamba; Bwalya Daka Lalusha; Edford Sinkala; Melissa Chola Kapulu; Paul Kelly Journal: Vaccine Date: 2012-07-10 Impact factor: 3.641
Authors: John Louis-Auguste; Stephen Greenwald; Michelo Simuyandi; Rose Soko; Rose Banda; Paul Kelly Journal: BMC Gastroenterol Date: 2014-01-15 Impact factor: 3.067